Clinical trial reportJournal of Crohn's & colitisPublished
Serum protein profiles differ with adalimumab and ustekinumab treatment in moderately to severely active Crohn's disease
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of Crohn's & colitis
- Published
- Topic
- Disease research
- Subject terms
- Humans; Crohn Disease; Blood Proteins; Anti-Inflammatory Agents; Interleukins; Severity of Illness Index; Double-Blind Method; Adult; Middle Aged; Female; Male; Adalimumab
- PubMed ID
- 41258994
- Added to directory
- Source checked